Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Cardlytics, Inc. (NASDAQ: CDLX), an advertising platform in banks' digital channels, has announced the granting of 49,900 restricted stock units to seven newly hired employees.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Cardlytics, Inc. (NASDAQ: CDLX), an advertising platform in banks' digital channels, has announced the granting of 49,900 restricted stock units to seven newly hired employees. The grants were approved by the Compensation Committee of Cardlytics' Board of Directors on August 19, 2024, as material inducements to employment under Nasdaq Listing Rule 5635(c)(4).
The restricted stock units were granted under the Cardlytics, Inc. 2022 Inducement Plan. For all recipients, 50% of the units will vest on the first anniversary of the grant date, with the remaining 50% vesting quarterly over the subsequent 12 months, subject to continuous service with Cardlytics.
Positive
- Attraction of new talent with stock-based compensation
- Alignment of employee interests with company performance through equity grants
Negative
- Potential dilution of existing shareholders' equity
Details
News Market Reaction – CDLX
The recorded move for CDLX in the trading session of this news was +7.24%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ATLANTA, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), an advertising platform in banks’ digital channels, today announced that, on August 19, 2024, the Compensation Committee of Cardlytics’ Board of Directors granted an aggregate of 49,900 restricted stock units of Cardlytics to seven newly hired employees. The restricted stock units were granted as material inducements to employment with Cardlytics in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Cardlytics, Inc. 2022 Inducement Plan (the “2022 Inducement Plan”).
For all of the grant recipients,
About Cardlytics
Cardlytics (NASDAQ: CDLX) is a digital advertising platform. We partner with financial institutions to run their rewards programs that promote customer loyalty and deepen relationships. In turn, we have a secure view into approximately 1 of every 2 card-based transactions in the U.S., allowing us to see where and when consumers are spending their money. We use these insights to help marketers identify, reach, and influence likely buyers at scale, as well as measure the true sales impact of marketing campaigns. Headquartered in Atlanta, Cardlytics has offices in Menlo Park, Los Angeles, New York, and London. Learn more at www.cardlytics.com.
Contacts:
Public Relations:
pr@cardlytics.com
Investor Relations:
ir@cardlytics.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.